VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
-6.04%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$1.45B
AUM Growth
-$206M
(-12%)
Cap. Flow
+$45.7M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
69.2%
Holding
57
New
2
Increased
7
Reduced
7
Closed
3
Top Buys
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$45.3M |
| 2 |
Geron
GERN
|
$20.7M |
| 3 |
Vera Therapeutics
VERA
|
$15.7M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$5.9M |
| 5 |
Celldex Therapeutics
CLDX
|
$4.9M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$15.3M |
| 2 |
ESSA Pharma
EPIX
|
$10.6M |
| 3 |
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
|
$9.01M |
| 4 |
Relmada Therapeutics
RLMD
|
$4.76M |
| 5 |
Larimar Therapeutics
LRMR
|
$4.31M |
Sector Composition
| 1 | Healthcare | 84.74% |
| 2 | Financials | 11.77% |
| 3 | Materials | 3.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELEV
51
DELISTED
Elevation Oncology
ELEV
| $1.25M | 0.09% |
496,844
| – | – |
|
52
Precision BioSciences
DTIL
$59.3M
| $432K | 0.03% |
4,675
| – | – |
|
|
MTCR
53
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $89K | 0.01% |
146,426
| – | – |
|
|
EIGR
54
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $35K | ﹤0.01% |
139
| – | – |
|
|
55
ESSA Pharma
EPIX
$11.2M
| – | – |
-744,058
| Closed | -$10.6M |
|
|
56
Larimar Therapeutics
LRMR
$342M
| – | – |
-399,830
| Closed | -$4.31M |
|
|
ZGNX
57
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-105,000
| Closed | -$1.71M |
|